Inclusion Criteria:  For inclusion in the study participants should fulfil the following criteria:  Participants with suitable veins for cannulation or repeated venipuncture. Females must have a negative pregnancy test at the Screening Visit and within 24 hours prior to dosing, must not be lactating and must be of non- childbearing potential Male participant must adhere to the contraception methods. Have a BMI between 18 and 29.9 kg/m^2 inclusive and weigh at least 50 kg and no more than 100 kg inclusive. Provision of signed and dated, written informed consent prior to any study specific procedures.  Exclusion Criteria:  Participants will not enter the study if any of the following exclusion criteria are fulfilled:  History or presence of gastrointestinal, hepatic or renal disease or any important disease or disorder. Any clinically important illness, medical/surgical procedure or trauma within 4 weeks of the first administration of study intervention. Any clinically significant abnormalities in clinical chemistry, haematology, or urinalysis. Any positive result on screening for serum hepatitis B surface antigen, hepatitis C antibody, and Human immunodeficiency virus antibody. Abnormal vital signs. 6 History of drug abuse or alcohol abuse.  7. History of severe allergy/hypersensitivity or ongoing clinically important allergy/hypersensitivity.  8. Participants who are vegans or have medical dietary restrictions. 9. Participants tested positive for COVID-19 at the time of randomisation or have been previously hospitalised with COVID-19 infection.